Researchers discover protein to better forecast prognosis of prostate cancer patients

Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology in Houston have identified a biomarker that will aid in more accurately determining the prognosis for prostate cancer patients, a finding that could have further implications for anti-cancer drug discovery and ultimately, cancer prevention.

http://ift.tt/1nId9H1